Research seminar: The design of clinical trials: what do the names mean?
Professor Graham Law will be giving the next seminar in the Community and Health Research Unit series. The seminar is online and in person and all are welcome.
Title: “The design of Clinical Trials: what do the names mean?”
You may have heard that Clinical Trials are typically conducted in phases. In this talk, I will try to explain some of these.
The phase, 1 to 4, indicates the stage of development and testing a drug or treatment has reached. These include Phase I (safety and dosage), Phase II (effectiveness and side effects), Phase III (large-scale effectiveness and monitoring of side effects), and Phase IV (post-marketing surveillance).
But we have found that an essential component of trial design has been the ‘feasibility clinical trial’. This may be similar to but often confused with the ‘pilot trial’. I will try to explain these also.
Graham Law is Professor in Medical Statistics in College of Social Science. He has published extensively in epidemiology and medical statistics. He has worked on many different diseases, particularly diabetes. He is co-Director of the Lincoln Clinical Trials Unit (https://ctu.lincoln.ac.uk/).
Graham is also the School Senior Leadership Team Chair, a member of the College Inclusion Committee and the Leads University Research Data Management Group.
His subject specialisms are: diabetes, trials, sleep, metabolic and cardiovascular health, ambulance services.
Book your place
To book your free place, please email your details to Susan Bowler firstname.lastname@example.org.
Story submitted by Susan Bowler